Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
0.68
- 0.01 (-1.56%)
12:56 PM ET on Feb 27, 2017
Delayed at least 20 minutes.
Day High 0.71
Day Low 0.68
52-Week High 4.90
Volume 732,084
Print Friendly